Acridine and its derivatives: a patent review (2009–2013)

B Zhang, X Li, B Li, C Gao, Y Jiang - Expert opinion on therapeutic …, 2014 - Taylor & Francis
Introduction: Acridine derivatives have been extensively explored as potential therapeutic
agents for the treatment of a number of diseases, such as cancer, Alzheimer's, and bacterial …

Acridine/acridone: a simple scaffold with a wide range of application in oncology

P Belmont, I Dorange - Expert Opinion on Therapeutic Patents, 2008 - Taylor & Francis
Background: The acridine scaffold is of interest since its DNA affinity and intercalative
properties make it an important pharmacophore for the design of antitumor drugs targeting …

Xanthone-1, 2, 4-triazine and Acridone-1, 2, 4-triazine Conjugates: Synthesis and anticancer activity

S Santra, AD Sharapov, RF Fatykhov, AP Potapova… - Pharmaceuticals, 2023 - mdpi.com
A total of 21 novel xanthone and acridone derivatives were synthesized using the reactions
of 1, 2, 4-triazine derivatives with 1-hydroxy-3-methoxy-10-methylacridone, 1, 3-dimethoxy …

The synthesis of imidazo [1, 5-a] quinolines via a decarboxylative cyclization under metal-free conditions

Z Yan, C Wan, Y Yang, Z Zha, Z Wang - RSC advances, 2018 - pubs.rsc.org
The synthesis of imidazo[1,5- a ]quinolines via a decarboxylative cyclization under metal-free
conditions - RSC Advances (RSC Publishing) DOI:10.1039/C8RA03786H Royal Society of …

Acid–base equilibrium and self-association in relation to high antitumor activity of selected unsymmetrical bisacridines established by extensive chemometric analysis

M Kosno, T Laskowski, JE Frackowiak, A Potęga… - Molecules, 2022 - mdpi.com
Unsymmetrical bisacridines (UAs) represent a novel class of anticancer agents previously
synthesized by our group. Our recent studies have demonstrated their high antitumor …

Metabolic profiles of new unsymmetrical bisacridine antitumor agents in electrochemical and enzymatic noncellular systems and in tumor cells

A Mieszkowska, AM Nowicka, A Kowalczyk, A Potęga… - Pharmaceuticals, 2021 - mdpi.com
New unsymmetrical bisacridines (UAs) demonstrated high activity not only against a set of
tumor cell lines but also against human tumor xenografts in nude mice. Representative UA …

Acridine derivatives: A patent review (2009–2010)

J Kaur, P Singh - Expert Opinion on Therapeutic Patents, 2011 - Taylor & Francis
Introduction: Acridines are highly important heterocyclic compounds with immense
biological significance as they act as the central core of antitumor, anti-protozoan, antiviral …

Electrochemical simulation of metabolism for antitumor-active imidazoacridinone C-1311 and in silico prediction of drug metabolic reactions

A Potęga, D Żelaszczyk, Z Mazerska - Journal of Pharmaceutical and …, 2019 - Elsevier
The metabolism of antitumor-active 5-diethylaminoethylamino-8-hydroxyimidazoacridinone
(C-1311) has been investigated widely over the last decade but some aspects of molecular …

The imidazoacridinone antitumor drug, C-1311, is metabolized by flavin monooxygenases but not by cytochrome P450s

A Potega, E Dabrowska, M Niemira, A Kot-Wasik… - Drug Metabolism and …, 2011 - Elsevier
5-Diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311) is an antitumor agent that
is also active against autoimmune diseases. The intention of the present studies was to …

Acridones: a relatively lesser explored heterocycle for multifactorial diseases

R Kumar, S Sharma, D Prasad - Key Heterocycle Cores for Designing …, 2018 - Elsevier
Biological as well as other important aspects of acridine have been studied and reviewed by
number of prominent researchers so far. But interestingly, from the 2000s, acridones, the …